Dare Bioscience Inc (NAS:DARE)
$ 3.1855 -0.0045 (-0.14%) Market Cap: 27.75 Mil Enterprise Value: 21.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Q4 2020 Dare Bioscience Inc Earnings Call Transcript

Mar 30, 2021 / 08:30PM GMT
Release Date Price: $19.8
Operator

Welcome to the conference call hosted by Daré Bioscience to review the company's financial results for the year ended December 31, 2020, and to provide a general business update. This call is being recorded. My name is Sara, and I will be your operator today.

With us today are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; John Fair, Daré's Chief Strategy Officer; and Lisa Walters-Hoffert, Daré's Chief Financial Officer.

Ms. Johnson, please proceed.

Sabrina Martucci Johnson;Bioscience
DarÃ;Inc. - President, CEO, Secretary & Director

© -

Thank you. Good afternoon, and welcome to our 2020 financial results and business update call for Daré Bioscience. Our plan today is to review last year's financial results, discuss notable achievements since our last call in November and use the time to highlight developments and milestones anticipated for 2021.

Before I begin, I would like to remind you that today's discussion will include forward-looking statements within the meaning of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot